CALL/AMGEN/220/0.1/17.01.25 | Market Closed - BOERSE MUENCHEN 19:26:28 28/06/2024 BST | ||
| 9.08 EUR | +0.55% |
|
| Current month | +7.84% | ||
| 1 month | +12.80% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 9.08 | +0.55% |
| 27/06/24 | 9.03 | -2.48% |
| 26/06/24 | 9.26 | -5.89% |
| 25/06/24 | 9.84 | +4.79% |
| 24/06/24 | 9.39 | +5.15% |
Real-time BOERSE MUENCHEN
Last update June 28, 2024 at 07:26 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GZ9DZR |
| ISIN | DE000GZ9DZR8 |
| Date issued | 28/02/2023 |
| Strike | 220 $ |
| Maturity | 17/01/2025 (201 Days) |
| Parity | 10 : 1 |
| Emission price | 3.73 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.45 € |
|---|---|
| Lowest since issue | 2.223 € |
| Delta | 0.92x |
| Omega | 2.963 |
| Premium | 1.55x |
| Gearing | 3.21x |
| Moneyness | 1.420 |
| Difference Strike | -92.45 $ |
| Difference Strike % | -42.02% |
| Spread | 0.07 € |
| Spread % | 0.77% |
| Theoretical value | 9.085 |
| Implied Volatility | 35.60 % |
| Total Loss Probability | 10.56 % |
| Intrinsic value | 8.633 |
| Present value | 0.4524 |
| Break even | 317.29 € |
| Theta | -0.02x |
| Vega | 0.03x |
| Rho | 0.1x |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Warrants
- Warrant
